Aradigm Corp.

Aradigm Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.11
Market Cap
$19.76 M
Shares Outstanding
15.2 M
Public Float
9.56 M

Profile

Address
3929 Point Eden Way
Hayward California 94545
United States
Employees -
Website http://www.aradigm.com
Updated 09/14/2018
Aradigm Corp. operates as a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Its technologies include diabetes and pain management, AERx essence devices. The company was founded in 1991 and is headquartered in Hayward, CA.

Financials

View All

John M. Siebert
Executive Chairman, Chief Executive Officer & CFO
Theresa Matkovits
Director